67 related articles for article (PubMed ID: 21055355)
41. [siRNA-mediated silencing of ClC-2 gene inhibits proliferation of human U-87 glioma cells].
Yang XY; Lai XG; Zhang Y; Pei JM; Yang AG; Zhou SS
Ai Zheng; 2006 Jul; 25(7):805-10. PubMed ID: 16831268
[TBL] [Abstract][Full Text] [Related]
42. TCAP knockdown by RNA interference inhibits myoblast differentiation in cultured skeletal muscle cells.
Markert CD; Ning J; Staley JT; Heinzke L; Childers CK; Ferreira JA; Brown M; Stoker A; Okamura C; Childers MK
Neuromuscul Disord; 2008 May; 18(5):413-22. PubMed ID: 18440815
[TBL] [Abstract][Full Text] [Related]
43. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
44. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
Du YF; Xing YF; Zeng FQ; Lu P; Liu XY; Xiao YJ
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):489-94. PubMed ID: 18069626
[TBL] [Abstract][Full Text] [Related]
45. Pituitary homeobox 2 in thyroid tumorigenesis: extension from its classical developmental role.
Xing M
Cell Cycle; 2010 Apr; 9(8):1465. PubMed ID: 20421721
[No Abstract] [Full Text] [Related]
46. Interfering with the progression of breast cancer.
Harrington M
Lab Anim (NY); 2014 Mar; 43(3):73. PubMed ID: 24552901
[No Abstract] [Full Text] [Related]
47. Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment.
Teo WW; Sukumar S
Breast Cancer Res; 2014 May; 16(2):306. PubMed ID: 25927933
[TBL] [Abstract][Full Text] [Related]
48. Inference from RNA interference: Suggestions to our authors.
Gronemeyer H
Int J Cancer; 2020 Jan; 146(1):9. PubMed ID: 31454067
[No Abstract] [Full Text] [Related]
49. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target.
Kleiber K; Strebhardt K; Martin BT
Anticancer Res; 2007; 27(1A):55-61. PubMed ID: 17352216
[TBL] [Abstract][Full Text] [Related]
50. RNA interference libraries prove their worth in hunt for tumor suppressor genes.
Downward J
Cell; 2005 Jun; 121(6):813-5. PubMed ID: 15960967
[TBL] [Abstract][Full Text] [Related]
51. [Inhibition of the expression of FHL2 by RNA interference].
Wang ZY; Zhou L; Ding LH; Lv QJ; Yang X; Ye QN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Nov; 26(11):1149-51. PubMed ID: 21055355
[TBL] [Abstract][Full Text] [Related]
52. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
[TBL] [Abstract][Full Text] [Related]
53. FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1.
Sun J; Yan G; Ren A; You B; Liao JK
Circ Res; 2006 Sep; 99(5):468-76. PubMed ID: 16888242
[TBL] [Abstract][Full Text] [Related]
54. Functional gene silencing mediated by chitosan/siRNA nanocomplexes.
Ji AM; Su D; Che O; Li WS; Sun L; Zhang ZY; Yang B; Xu F
Nanotechnology; 2009 Oct; 20(40):405103. PubMed ID: 19752491
[TBL] [Abstract][Full Text] [Related]
55. Deletion of the FHL2 gene attenuates the formation of atherosclerotic lesions after a cholesterol-enriched diet.
Chu PH; Yeh HI; Wu HH; Hong RC; Shiu TF; Yang CM
Life Sci; 2010 Feb; 86(9-10):365-71. PubMed ID: 20096293
[TBL] [Abstract][Full Text] [Related]
56. [Mapping of FHL2 transcription activation domain].
Yan JH; Ye QN; Fang Y; Zhu JH; Huang CF
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):643-8. PubMed ID: 12883635
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
